These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 18670743

  • 1. Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC.
    Yang P, Liang M, Zhang Y, Shen B.
    Adv Ther; 2008 Aug; 25(8):787-94. PubMed ID: 18670743
    [Abstract] [Full Text] [Related]

  • 2. [Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation].
    Wang YB, Chen MH, Yan K, Yang W, Dai Y, Yin SS.
    Ai Zheng; 2005 Jul; 24(7):827-33. PubMed ID: 16004809
    [Abstract] [Full Text] [Related]

  • 3. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection.
    Kagawa T, Koizumi J, Kojima S, Nagata N, Numata M, Watanabe N, Watanabe T, Mine T, Tokai RFA Study Group.
    Cancer; 2010 Aug 01; 116(15):3638-44. PubMed ID: 20564097
    [Abstract] [Full Text] [Related]

  • 4. [Radiofrequency ablation with or without transcather arterial chemoembolization for management of hepatocellular carcinoma].
    Li ZR, Kang Z, Qian JS, Zhu KS, Jiang ZB, Huang MS, Guan SH, Shan H.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov 01; 27(11):1749-51. PubMed ID: 18024306
    [Abstract] [Full Text] [Related]

  • 5. [Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm].
    Yang MJ, An SY, Moon EJ, Lee MS, Hwang JA, Cheong JY, Won JH, Kim JK, Wang HJ, Cho SW.
    Korean J Hepatol; 2009 Dec 01; 15(4):474-85. PubMed ID: 20037266
    [Abstract] [Full Text] [Related]

  • 6. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
    Zhao M, Wang JP, Li W, Huang ZL, Zhang FJ, Fan WJ, Zhang L, Li XS, Pan CC, Wu PH.
    Zhonghua Yi Xue Za Zhi; 2011 May 10; 91(17):1167-72. PubMed ID: 21756768
    [Abstract] [Full Text] [Related]

  • 7. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
    Yamagiwa K, Shiraki K, Yamakado K, Mizuno S, Hori T, Yagi S, Hamada T, Iida T, Nakamura I, Fujii K, Usui M, Isaji S, Ito K, Tagawa S, Takeda K, Yokoi H, Noguchi T.
    J Gastroenterol Hepatol; 2008 Mar 10; 23(3):482-90. PubMed ID: 18086115
    [Abstract] [Full Text] [Related]

  • 8. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy.
    Bloomston M, Binitie O, Fraiji E, Murr M, Zervos E, Goldin S, Kudryk B, Zwiebel B, Black T, Fargher S, Rosemurgy AS.
    Am Surg; 2002 Sep 10; 68(9):827-31. PubMed ID: 12356160
    [Abstract] [Full Text] [Related]

  • 9. [Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma].
    Li CX, Wu PH, Fan WJ, Huang JH, Zhang FJ, Zhang L, Gu YK, Zhao M, Gao F, Jiao DC.
    Zhonghua Yi Xue Za Zhi; 2009 Mar 24; 89(11):754-7. PubMed ID: 19595104
    [Abstract] [Full Text] [Related]

  • 10. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.
    Wang W, Shi J, Xie WF.
    Liver Int; 2010 May 24; 30(5):741-9. PubMed ID: 20331507
    [Abstract] [Full Text] [Related]

  • 11. Comparable survival in patients with unresectable hepatocellular carcinoma treated by radiofrequency ablation or transarterial chemoembolization.
    Chok KS, Ng KK, Poon RT, Lam CM, Yuen J, Tso WK, Fan ST.
    Arch Surg; 2006 Dec 24; 141(12):1231-6. PubMed ID: 17178966
    [Abstract] [Full Text] [Related]

  • 12. Combined treatment, TACE and RF ablation, in HCC: preliminary results.
    Gasparini D, Sponza M, Marzio A, Zanardi R, Bazzocchi M, Cemal Y.
    Radiol Med; 2002 Dec 24; 104(5-6):412-20. PubMed ID: 12589262
    [Abstract] [Full Text] [Related]

  • 13. Radiofrequency ablation and chemoembolization for hepatocellular carcinoma.
    Georgiades CS, Hong K, Geschwind JF.
    Cancer J; 2008 Dec 24; 14(2):117-22. PubMed ID: 18391617
    [Abstract] [Full Text] [Related]

  • 14. [Comparision of different interventional therapies for primary liver cancer].
    Liu YM, Qin H, Wang CB, Fang XH, Ma QY.
    Zhonghua Zhong Liu Za Zhi; 2007 Mar 24; 29(3):232-5. PubMed ID: 17649645
    [Abstract] [Full Text] [Related]

  • 15. [Cytokine-induced killer cell fusion to lower recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization sequentially combined with radiofrequency ablation: a randomized trial].
    Zhao M, Wu PH, Zeng YX, Xia JC, Zhang FJ, Xian LJ, Zhang YP, Zhou K, Fan WJ, Zhang L, Gao F, Zhou QM.
    Zhonghua Yi Xue Za Zhi; 2006 Jul 11; 86(26):1823-8. PubMed ID: 17054858
    [Abstract] [Full Text] [Related]

  • 16. [Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
    Chen XM, Luo PF, Lin HH, Zhou ZJ, Shao PJ, Fu L, Li WK.
    Ai Zheng; 2004 Jul 11; 23(7):829-32. PubMed ID: 15248922
    [Abstract] [Full Text] [Related]

  • 17. Cytokine-induced killer cells in combination with transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma patients.
    Huang ZM, Li W, Li S, Gao F, Zhou QM, Wu FM, He N, Pan CC, Xia JC, Wu PH, Zhao M.
    J Immunother; 2013 Jun 11; 36(5):287-93. PubMed ID: 23719239
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of combined percutaneous radio-frequency ablation and percutaneous ethanol injection after transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Zhang FJ, Wu PH, Zhao M, Gu YK, Zhang L, Tan ZB.
    Zhonghua Zhong Liu Za Zhi; 2005 Apr 11; 27(4):248-50. PubMed ID: 15949431
    [Abstract] [Full Text] [Related]

  • 19. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review.
    Jansen MC, van Hillegersberg R, Chamuleau RA, van Delden OM, Gouma DJ, van Gulik TM.
    Eur J Surg Oncol; 2005 May 11; 31(4):331-47. PubMed ID: 15837037
    [Abstract] [Full Text] [Related]

  • 20. [Clinical features of liver abscess developed after radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma].
    Kim MH, Choi MS, Choi YS, Kim DY, Lee JM, Paik SW, Lee JH, Koh KC, Yoo BC, Choi D, Rhee JC.
    Korean J Hepatol; 2006 Mar 11; 12(1):55-64. PubMed ID: 16565606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.